EXACT Sciences Corporation

Exact Sciences Corporation provides cancer screening and diagnostic tests in the United States and internationally. Its offerings include Cologuard, a non-invasive stool-based DNA test for colorectal cancer and pre-cancer biomarkers, along with Cologuard Plus, Cancerguard, and genetic testing. The company also offers Oncotype DX tests for breast and colon cancer, Oncodetect, OncoExTra for tumor profiling, and Riskguard, a hereditary cancer test. Its pipeline focuses on advancing screening and diagnostics across risk assessment, early detection, treatment selection, and recurrence monitoring. Exact Sciences has license agreements with the Mayo Foundation, Johns Hopkins University, and Freenome Holdings. Incorporated in 1995, it is headquartered in Madison, Wisconsin.